HRS 2024: Vektor Medical’s vMap Technology to be Highlighted in Rhythm Theater and Eight Posters
Data Demonstrates vMap’s Ability to Locate Arrhythmia Sources and Deliver Critical Value SAN DIEGO–(BUSINESS WIRE)–#arrhythmias—Vektor Medical,... Read more.
Perion Launches Global DOOH ‘Green Curated Deals’ Through the Hivestack Platform and Scope3
New solution makes it easy for advertisers to find and buy lower carbon emissions inventory for DOOH campaigns NEW YORK & TEL AVIV, Israel–(BUSINESS WIRE)–#tech–Perion... Read more.
Aramark Recognized as One of the Best Places to Work in Healthcare in 2024
PHILADELPHIA–(BUSINESS WIRE)–$ARMK—Aramark Healthcare+, a leader in healthcare dining, nutrition, and facilities services, has been selected by... Read more.
Bowman Awarded Contract from ADOT for ASU Tempe Pedestrian Grade Separated Crossing
RESTON, Va.–(BUSINESS WIRE)–Bowman Consulting Group Ltd. (the Company or Bowman) (NASDAQ: BWMN), a national engineering services firm delivering infrastructure... Read more.
Leading Proxy Advisory Firm Glass Lewis Supports All Xperi Board Candidates
Glass Lewis Joins ISS in Recommending Xperi Stockholders Vote “FOR” All Company Nominees on the Blue Proxy Card Glass Lewis Concludes Rubric Capital Has Failed... Read more.
PTEN Research Foundation Further Strengthens its Scientific Advisory Board with the Appointment of Two New Senior Leaders from the Pharmaceutical Industry
Rare disease charity PTEN Research Foundation welcomes two new senior leaders from the pharmaceutical industry, Professor Sir Mene Pangalos and Dr Donald Ogilvie... Read more.
Volato Reports First Quarter 2024 Results
Announces $14.5 Million in New Financing Grew Flight Hours 39% and Blended Yield 8% Year-over-Year Expect Delivery of 10-12 New Aircraft in FY 2024 ATLANTA–(BUSINESS... Read more.
Guerrilla RF Reports Record First Quarter 2024 Results and Gross Margin Expansion
Record revenue quarter of $5.1 million Gross Margin expands 640 basis points sequentially over prior quarter GREENSBORO, N.C.–(BUSINESS WIRE)–$GUER–Guerrilla... Read more.
Blackstone Life Sciences Launches Uniquity Bio to Develop Novel Medicines in Immunology & Inflammation
Blackstone Commits $300M in Financing Uniquity Bio Set to Start Phase 2 Clinical Trials in COPD & Asthma with Novel Anti-TSLP Monoclonal Antibody NEW YORK–(BUSINESS... Read more.
Oncoinvent to Present at Cantor Fitzgerald Frontiers in Radiopharma Virtual Summit
OSLO, Norway–(BUSINESS WIRE)–Oncoinvent AS, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced... Read more.